Access cutting-edge acute pancreatitis treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access acute pancreatitis specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related acute pancreatitis treatment provided free
The goal of the current pilot clinical trial is to evaluate the safety and tolerability of pirfenidone in patients with predicted moderately severe and severe acute pancreatitis. Pirfenidone is currently approved by FDA for the treatment of idiopathic pulmonary fibrosis. Now, over 5 years of data has accumulated demonstrating safety of its use in humans. The investigators' preclinical data suggest that pirfenidone is very effective in reducing the severity of acute pancreatitis in animal models.
Sponsor: University of Alabama at Birmingham
Check if you qualify for this acute pancreatitis clinical trial in Birmingham, AL
If you're searching for acute pancreatitis treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acute pancreatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.